Atezolizumab,as a new PD-L1 inhibitor drug,has become one of the hot spots in tumor immunotherapy research.This review takes atezolizumab as the research object,uses patent technology analysis to study the status of related patent applications,and focuses on the patent applications of atezolizumab in China from the perspective of its technical themes and patent layout,so as to provide some effective references and suggestions for domestic research institutions and enterprises in R&D and patent layout strategies of atezolizumab.
NETL
NSTL
万方数据
